Story
MOEX Russia Index Gains 0.44% as Energy and Mining Stocks Advance
Summary
Russia's benchmark stock index closed higher on Tuesday, supported by advances in the energy, mining, and manufacturing sectors, even as more individual stocks on the exchange declined than advanced.
Russia's main stock market benchmark, the MOEX Russia Index, finished Tuesday's session in positive territory, closing with a gain of 0.44%. The advance was primarily driven by strength in the nation's key energy, mining, and manufacturing sectors, according to market data from Investing.com.
Market Internals
Despite the index's rise, market breadth on the Moscow Exchange was negative. A total of 123 stocks declined, outnumbering the 112 that advanced. An additional 20 stocks closed the session unchanged.
In a related development, the Russian Volatility Index (RVI), which measures the implied volatility of MOEX Russia Index options, edged higher by 0.09% to finish at 33.23.
Top Movers
The session's leading performers on the MOEX Russia Index included several prominent companies:
Ad- Moskovskaya Birzha PJSC (MCX:MOEX): The operator of the Moscow Exchange was the top gainer, surging 2.77%.
- ROSSETI PJSC (MCX:FEES): The electric grid operator advanced 2.31%.
- VK Company Ltd (MCX:VKCO): The technology firm's shares rose 1.67%.
On the other side of the ledger, several major stocks weighed on the market:
- Mobil'nye Telesistemy PJSC (MCX:MTSS): The telecommunications giant was the biggest laggard, falling 2.15%.
- AK ALROSA PJSC (MCX:ALRS): The diamond mining company's stock dropped 1.90%.
- Rosneft PJSC (MCX:ROSN): The oil major saw its shares decline by 1.56%.
Commodities and Currencies
In the broader markets, West Texas Intermediate (WTI) crude oil futures for November delivery fell significantly, while Brent crude for December delivery posted a marginal loss. The Russian ruble was stable, with both the USD/RUB and EUR/RUB currency pairs showing minimal change during the session.
Read next
More on Stocks
Dyne Therapeutics Shares Rise on Positive 12-Month Data for DM1 Drug
The clinical-stage biotech company reported significant functional improvements in patients with myotonic dystrophy type 1 (DM1) in its Phase 1/2 ACHIEVE trial, boosting investor confidence.
Accelevation Prices IPO at $18 Per Share Ahead of Nasdaq Debut
Accelevation Holdings Corp. has priced its initial public offering of 30 million shares at $18.00 each, with the majority of shares being sold by existing stockholders. The company is set to begin trading on the Nasdaq under the ticker ACCV.
TSA to Remove Chairs from Airport ID Checkpoints, Drawing Union Criticism
The Transportation Security Administration will require its officers to stand while checking IDs at US airports, a move the agency says enhances security but a major union decries as a disregard for worker safety.
Robinhood to Introduce 24/7 Trading with Weekend Access for Select US Stocks
The online brokerage announced it will allow users to trade a selection of US stocks and ETFs around the clock on weekends, a first for the platform and part of a broader industry shift toward continuous market access.